（在中華人民共和國註冊成立的股份有限公司） （股份代號：2402） 海外監管公告 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部 或任何部分內容而產生或因依賴該等內容而引致之任何損失承擔任何責任。 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲 載 列 北 京 億 華 通 科 技 股 份 有 限 公 司（「 本公司 」）於 上 海 證 券 交 易 所 網 站 (www.sse.com.cn)所刊發的公告，僅供參考。 承董事會命 北京億華通科技股份有限公司 董事長 中國，北京 2025年8月1日 於 本 公 告 日 期，本 公 司 董 事 會 成 員 包 括 執 行 董 事 張 國 強 先 生、宋 海 英 女 士 及 戴東哲女士；非執行董事宋峰先生；獨立非執行董事紀雪洪先生、陳素權先生及 李志杰先生；及職工代表董事張紅黎女士。 证券代码：688339 证券简称：亿华通 公告编号：2025-040 北京亿华通科技股份有限公司 股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容 ...

证券代码：688339 证券简称：亿华通 公告编号：2025-040 北京亿华通科技股份有限公司 股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 一、减持主体减持前基本情况 1 上述减持主体无一致行动人。 二、减持计划的实施结果 （一）相关股东因以下事项披露减持计划实施结果： 减持计划实施完毕 重要内容提示： 公司于 2025 年 6 月 30 日披露了《北京亿华通科技股份有限公司股东减 持股份计划公告》（公告编号：2025-038），截至该公告披露日，公司股东周竹青 女士持有北京亿华通科技股份有限公司（以下简称"公司"）股份 280,000 股（占 公司总股本的 0.12%，占公司 A 股总股本的 0.14%）。该股东计划减持其所持有的 公司股份合计数量不超过 70,000 股,即不超过公司总股本的 0.03%。 减持计划的实施结果情况：截至本公告披露日，上述减持计划已实施完 毕，该股东实际减持股份 70,000 股，其当前持有公司股份 210，000 股，占公司 总股本的 0.09%。 ...

Group 1 - The company announced that shareholder Ms. Zhou Zhuqing has completed her reduction plan [1] - From July 22, 2025, to July 31, 2025, she reduced her holdings by 70,000 shares at a price range of 22.71 to 23.75 yuan per share [1] - The total amount of the reduction was 1.6118 million yuan, accounting for 0.03% of the company's total share capital [1] Group 2 - After the reduction, Ms. Zhou holds 210,000 shares, which represents 0.09% of the company's total share capital [1]

Group 1 - China's Q2 GDP growth reached 5.2%, exceeding expectations, leading to a rally in Hong Kong stocks [1] - The Hang Seng Technology Index surged by 2.8%, while the Hang Seng Index and the National Enterprises Index rose by 1.6% and 1.65% respectively [1][2] - Major technology stocks performed strongly, with Alibaba rising nearly 7%, Meituan and Baidu up over 4%, and Tencent increasing by 3.5% [2][4] Group 2 - The cryptocurrency sector faced challenges, with Bitcoin dropping below $117,000, leading to a decline in related stocks [2] - Real estate development investment in China fell by 11.2% year-on-year in the first half of the year, impacting domestic property stocks significantly [2][13] - The construction materials and cement stocks also saw declines, with major players like Jinyu Group and Anhui Conch Cement dropping over 6% and 4% respectively [11][12] Group 3 - The innovative drug sector showed strength, with companies like BeiGene and CSPC Pharmaceutical rising over 7% [7][8] - Stablecoin-related stocks performed well, with Yunfeng Financial increasing by 19.5% and Weishi Jiajie up by 11% [9][10] - The entertainment sector saw gains, with China Star Group rising over 10% and Tencent Music increasing by over 5% [15] Group 4 - Southbound funds recorded a net inflow of HKD 3.824 billion, indicating strong interest in Hong Kong stocks [18] - Analysts noted a shift in investor sentiment towards undervalued stocks, with some funds looking to capitalize on recent price corrections in major internet companies [17]

Group 1 - The Shanghai Stock Exchange has released the "Self-Regulatory Supervision Guidelines for Companies Listed on the Sci-Tech Innovation Board No. 5 - Sci-Tech Growth Tier" [1] - The reform does not impose additional listing thresholds for unprofitable companies entering the Sci-Tech Growth Tier, allowing 32 existing unprofitable companies to enter immediately upon the guideline's implementation [1] - Newly registered unprofitable companies will enter the Sci-Tech Growth Tier from the date of their listing [1] Group 2 - Investors participating in the subscription and trading of newly registered stocks in the Sci-Tech Growth Tier must sign a "Risk Disclosure Statement for the Sci-Tech Growth Tier" [2] - The 32 existing companies that have not yet removed the "U" designation include: Zejing Pharmaceutical, Junshi Biosciences, Frontier Biotech, Qingyun Technology, Hehui Optoelectronics, Jingjin Electric, BeiGene, Dize Pharmaceutical, Maiwei Biotech, Aojie Technology, Yuhong Pharmaceutical, Shouyao Holdings, Haichuang Pharmaceutical, CloudWalk Technology, Yifang Biotech, Obsidian Optics, Mengke Pharmaceutical, Nuo Cheng Jianhua, Xinke Mobile, Xinghuan Technology, Yutai Micro, Yuntian Lifa, Tianzhihang, Qi Anxin, Hanwujin, Yihua Tong, Aifute, Huizhiwei, Xinlian Integrated, Zhixiang Jintai, Shengke Communication, and Zhongjuxin [2]

证券代码：688339 证券简称：亿华通 公告编号：2025-039 北京亿华通科技股份有限公司 关于发行股份购买资产并募集配套资金 暨关联交易事项的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 本次交易的基本情况 北京亿华通科技股份有限公司（以下简称"公司"）拟通过以发行股份的方式 购买定州旭阳氢能有限公司（以下简称"旭阳氢能"）的100%股权并募集配套资 金（以下简称"本次交易"）。 2025年7月7日 根据上海证券交易所的相关规定，经公司申请，公司股票（证券简称：亿华 通，证券代码：688339）自2025年2月27日开市起停牌，具体内容详见公司于2025 年2月27日在上海证券交易所网站（www.sse.com.cn）披露的《北京亿华通科技 股份有限公司关于筹划发行股份购买资产并募集配套资金事项的停牌公告》（公 告编号：2025-002）以及于2025年3月6日披露的《北京亿华通科技股份有限公司 关于筹划发行股份购买资产并募集配套资金的进展并继续停牌的公告》（公告编 号：2025-004）。 20 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年6月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 北京億華通科技股份有限公司（「本公司」） 呈交日期: 2025年7月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | A | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 688339 | 說明 | | 於上海證券交易所科創板上市 | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 195,787,119 | RMB | | 1 RMB | | 195,787,119 | | 增加 / 減少 (-) | | | | | | RMB | | | | 本月底結存 | | | 195,787,119 | RMB | | 1 RMB | | 195,787,119 | | 2. 股份 ...

Core Viewpoint - The announcement details a share reduction plan by shareholder Zhou Zhuqing, who intends to sell up to 70,000 shares of Beijing Yihua Technology Co., Ltd. due to personal financial needs, representing 0.03% of the company's total share capital [1][2]. Summary by Sections Shareholder Information - Zhou Zhuqing holds 280,000 shares, accounting for 0.12% of the total share capital and 0.14% of the A-share capital of the company [1]. - The shares were acquired through divorce property division [1][2]. Reduction Plan Details - The planned reduction will occur through centralized bidding within three months, starting 15 trading days after the announcement [2]. - The reduction period is set from July 22, 2025, to October 21, 2025 [2]. - Zhou Zhuqing has committed to not reducing shares below the adjusted issue price if dividends or other capital adjustments occur [3]. Compliance and Commitments - Zhou Zhuqing will continue to adhere to previous commitments regarding shareholding and reduction limits, ensuring no impact on the company's governance structure or operational continuity [5]. - The reduction plan aligns with relevant laws and regulations, including the Securities Law of the People's Republic of China and the Shanghai Stock Exchange rules [5].

证券代码：688339 证券简称：亿华通 公告编号：2025-038 北京亿华通科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 截至本公告披露日，公司股东周竹青女士持有北京亿华通科技股份有限 公司（以下简称"公司"）股份 280,000 股（占公司总股本的 0.12%，占公司 A 股总股本的 0.14%）。 减持计划的主要内容：周竹青女士因自身资金需求，拟于减持计划披露 之日起 15 个交易日后的 3 个月内通过集中竞价方式减持其所持有的公司股份， 合计数量不超过 70,000 股，即不超过公司总股本的 0.03%。 | 股东名称 | 周竹青 | | | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 √否 | | | 直接持股 5%以上股东 | □是 √否 | | | 董事、监事和高级管理人员 | □是 √否 | | | 其他：董监高前配偶 | | | 持股数量 | 280,000股 | | 一、减持主体的基 ...

Group 1 - The company has revised its articles of association, eliminating the supervisory board and adding a worker representative director elected by employees [1][2] - Zhang Hongli has been elected as the worker representative director of the fourth board of directors, with her term lasting until the fourth board's term ends, which is three years from the approval at the 2024 annual general meeting [2] - Zhang Hongli meets all legal and regulatory qualifications for a director and has not faced any penalties from the China Securities Regulatory Commission or other relevant authorities [2] Group 2 - Zhang Hongli was born in 1983, holds a degree in financial accounting from Shandong Agricultural University, and has held various positions in finance, including her current role as financial manager at the company since 2009 [2]